Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification

SF Lax - Virchows Archiv, 2004 - Springer
Two types of endometrial carcinoma are distinguished with respect to biology and clinical
course. Type-I carcinoma is related to hyperestrogenism by association with endometrial …

BGCS uterine cancer guidelines: Recommendations for practice

S Sundar, J Balega, E Crosbie, A Drake… - European Journal of …, 2017 - Elsevier
BGCS uterine cancer guidelines: Recommendations for practice - ScienceDirect Skip to
main contentSkip to article Elsevier logo Journals & Books Search RegisterSign in View …

World Health Organization classification of tumours: Pathology & genetics of tumours of the urinary system and male genital organs

TY Chan - Urology, 2005 - goldjournal.net
This 2004 volume in the World Health Organization series on histologic and genetic typing
of human tumors covers tumors of the kidney, urinary system, prostate, testis and …

Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers

CA Hamilton, MK Cheung, K Osann, L Chen… - British journal of …, 2006 - nature.com
To compare the survival of women with uterine papillary serous carcinoma (UPSC) and
clear cell carcinoma (CC) to those with grade 3 endometrioid uterine carcinoma (G3EC) …

Factors associated with Type I and Type II endometrial cancer

AS Felix, JL Weissfeld, RA Stone, R Bowser… - Cancer Causes & …, 2010 - Springer
Objective We investigated risk factors for Type II (n= 176) vs. Type I (n= 1,576) endometrial
cancer (EC) in cases treated at Magee-Womens Hospital between 1996 and 2008. Methods …

Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium

WT Creasman, MF Kohler, F Odicino… - Gynecologic …, 2004 - Elsevier
OBJECTIVE: The purpose of this study was to evaluate patients with uterine papillary serous
carcinoma (UPSC), clear cell (CC), and grade 3 endometrioid (G3) surgically stage I …

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

E Bignotti, M Ragnoli, L Zanotti, S Calza… - British journal of …, 2011 - nature.com
Background: To date, no good marker for screening or disease monitoring of endometrial
cancer (EC) is available. The aims of this study were to investigate HE4 gene, protein …

New insights into endometrial cancer

L Paleari, S Pesce, M Rutigliani, M Greppi, V Obino… - Cancers, 2021 - mdpi.com
Simple Summary Endometrial cancer (EC) represents 90% of uterine cancer and to date its
standard clinical approach is still surgery and/or chemo-and radiotherapy. This mini-review …

Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes

A Mendivil, KM Schuler, PA Gehrig - Cancer control, 2009 - journals.sagepub.com
Background Understanding the etiology, presentation, evaluation, and management of
selected non-endometrioid endometrial adenocarcinomas of the uterine corpus is needed to …

Histotype-genotype correlation in 36 high-grade endometrial carcinomas

LN Hoang, MK McConechy, M Köbel… - The American journal …, 2013 - journals.lww.com
Endometrioid, serous, and clear cell carcinomas are the major types of endometrial
carcinoma. Histologic distinction between these different tumor types can be difficult in high …